Lab technician at work.
 

Directions  |  Office Forms  |  Frequently Asked Questions |  Contact Us
introduction
care providers
FAQs
forms
directions
cancers
robotic surgery
research
nutrition
patient forums
contact us

CPIWO began offering clinical trials &  cancer "protocols"  in February 2008.

---------------------

Clinical trials and clinical research at Chattanooga's Program in Women's Oncology must first be approved by an Institutional Review Board, which includes doctors, administrators, ethicists and members of the general public. Volunteers are fully informed of possible risks and sign a consent form before being accepted into a clinical trial.

 

Research

 

Chattanooga ’s Program in Women’s Oncology (CPIWO) is a member of the Gynecologic Oncology Group (GOG). this is a national cooperative group sponsored through the National Cancer Institute (NCI), dedicated to improving care in women with cancer.  Selected trials will now be available.  We also participate in trials sponsored through pharmaceutical companies.  We believe this gives the women in the South Eastern Tennessee Region the opportunity to participate in research that may be the next best treatment for their disease; it also gives women a chance to help other women with the same condition.

GOG Mission Statement: " The Gynecologic Oncology Group (GOG) is a non-profit organization (national) with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of Gynecologic malignancies. The Group (gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, nurses, statisticians, basic scientists, quality of life experts, data managers and administrative personnel is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. Continuous evaluation of our processes is utilized in order to constantly improve the quality of patient care." For more info, visit the GOG website at: www.gog.org .

Please feel free to call and ask questions about our research program: 423-266-3636.

 What is Clinical Research?

Clinical research, which involves clinical trials and other research protocols, are strictly controlled human studies of new and emerging therapies. This type of research involves real people participating in studies that are done to test whether a new drug, a new prevention strategy, or a new screening test is safe and effective in people.Clinical research allows doctors from various disciplines to evaluate new forms of treatment, how best to apply recent developments in medicine, and to ensure that patients have the opportunity to receive the latest state-of-the-art care

.--------------------------------------------------------------------------

CPIWO is offering these clinical trials:
(Check back for updates often.)

(CLICK ON A LINK TO GET DETAILED INFORMATION ON EACH TRIAL.)

Protocol EC-FV-04
A Randomized Phase II Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil/Caelyx) in Combination, Versus PLD Alone, in Subjects With Platinum-Resistant Ovarian Cancer.
The NCT # for this study is NCT00722592 link:
http://www.clinicaltrials.gov/ct2/show/NCT00722592?term=NCT00722592&rank=1

Protocol GOG-0212
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy.
The NCT # for this study is NCT00108745 Link: http://www.clinicaltrials.gov/ct2/show/NCT00108745?spons_ex=Y&id=NCT00108745&rank=1

Protocol GOG-0249
 Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
The NCT # for the study is NCT00262821 link: http://clinicaltrials.gov/ct2/show/NCT00807768?term=GOG+0249+NCT00807768&rank=1

Protocol GOG-0215
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
The NCT # for the study is NCT00305695 link: http://clinicaltrials.gov/ct2/show/NCT00305695?term=GOG+0215+NCT00305695&rank

CA163-196
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.
The NCT # for the study is NCT00883116 link:
http://clinicaltrials.gov/ct2/show/NCT00883116?term=NCT00883116&rank=1

AGO-OVAR-12 / 1199.15 
BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer.
The NCT # for the study is NCT01015118 link:
http://clinicaltrials.gov/ct2/show/NCT01015118?term=NCT01015118&rank=1

 


 

© 2008 Chattanooga's Program In Women's Oncology. All rights reserved.

Problems or questions with this site? Contact webmaster@cpiwo.com .